Rapid antibiotic susceptibility testing using resazurin bulk modified screen-printed electrochemical sensing platforms

Crane, Benjamin, Hughes, Jack P, Rowley Neale, Samuel J, Rashid, Mamun, Linton, Patricia E, Banks, Craig E ORCID: https://orcid.org/0000-0002-0756-9764 and Shaw, Kirsty J (2021) Rapid antibiotic susceptibility testing using resazurin bulk modified screen-printed electrochemical sensing platforms. The Analyst, 146 (18). pp. 5574-5583. ISSN 0003-2654

Preview

Published Version Available under License Creative Commons Attribution Non-commercial. Download (1MB) | Preview

Abstract

Urinary tract infections (UTIs) are one of the most common types of bacterial infection. UTIs can be associated with multidrug resistant bacteria and current methods of determining an effective antibiotic for UTIs can take up to 48 hours, which increases the chances of a negative prognosis for the patient. In this paper we report for the first time, the fabrication of resazurin bulk modified screen-printed macroelectrodes (R-SPEs) demonstrating them to be effective platforms for the electrochemical detection of antibiotic susceptibility in complicated UTIs. Using differential pulse voltammetry (DPV), resazurin was able to be detected down to 15.6 μM. R-SPEs were utilised to conduct antibiotic susceptibility testing (AST) of E. coli (ATCC® 25922) to the antibiotic gentamicin sulphate using DPV to detect the relative concentrations of resazurin between antibiotic treated bacteria, and bacteria without antibiotic treatment. Using R-SPEs, antibiotic susceptibility was determined after a total elapsed time of 90 minutes including the inoculation of the artificial urine, preincubation and testing time. The use of electrochemistry as a phenotypic means of identifying an effective antibiotic to treat a complicated UTI offers a rapid and accurate alternative to culture based methods for AST with R-SPEs offering an inexpensive and simpler alternative to other AST methods utilising electrochemical based approaches.